Eptifibatide

Cardiology

Cardiology · GP IIb/IIIa inhibitor

Eptifibatide

Dose

180 mcg/kg bolus × 2, 10 min apart; infusion 2 mcg/kg/min (halve if CrCl <50).

Indications

  • High-risk ACS/PCI (bailout)

Contraindications

  • Active bleed
  • Recent stroke
  • Severe HTN
  • Platelets <100

Use

Bailout antiplatelet during high-risk PCI.

Monitoring

Platelet count, bleeding.

Side effects

  • Bleeding
  • Thrombocytopenia

Always confirm dose against your local formulary / BNF before prescribing.

WardRound

WardRound

Clinical Decisions in Seconds